Parents' Perceptions of Novel Treatments for Child and Adolescent Specific Phobia and Anxiety Disorders.

Roberts, CL; Farrell, LJ; Waters, AM; Oar, EL; Ollendick, TH

Parents' Perceptions of Novel Treatments for Child and Adolescent Specific Phobia and Anxiety Disorders.

Roberts, CL Farrell, LJ Waters, AM Oar, EL Ollendick, TH

Permalink

Publisher:: Springer Science and Business Media LLC
Publication Type:: Journal Article
Citation:: Child Psychiatry Hum Dev, 2016, 47, (3), pp. 459-471
Issue Date:: 2016-06

Closed Access

	Filename	Description	Size
	s10578-015-0579-2.pdf	Published version	436.73 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Roberts, CL
dc.contributor.author	Farrell, LJ
dc.contributor.author	Waters, AM
dc.contributor.author	Oar, EL
dc.contributor.author	Ollendick, TH
dc.date.accessioned	2022-08-20T04:41:18Z
dc.date.available	2022-08-20T04:41:18Z
dc.date.issued	2016-06
dc.identifier.citation	Child Psychiatry Hum Dev, 2016, 47, (3), pp. 459-471
dc.identifier.issn	0009-398X
dc.identifier.issn	1573-3327
dc.identifier.uri	http://hdl.handle.net/10453/160536
dc.description.abstract	This study aimed to examine parents' perceptions of established treatments, including cognitive behaviour therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs), relative to novel treatments of D-cycloserine (DCS) and attention bias modification (ABM) augmented CBT to determine if novel treatments are perceived as more or less favorable than established treatments. Participants included parents of children with a specific phobia, enrolled in one of two randomized controlled trials of either one-session augmented DCS (n = 38, Gold Coast) or ABM augmented one-session treatment (n = 34, Brisbane), as well as parents from a community sample (n = 38). Parents of children with a specific phobia perceived CBT most favorably. There was no difference between the sites on perceptions of ABM. However, parents of children enrolled in the DCS trial perceived DCS more favorably than parents of children enrolled in the ABM trial and the community sample. These results demonstrate parents' greater acceptance of psychological treatments over pharmacological treatments for the treatment of childhood phobias, highlighting the importance of educating parents to novel treatments.
dc.format	Print
dc.language	eng
dc.publisher	Springer Science and Business Media LLC
dc.relation.ispartof	Child Psychiatry Hum Dev
dc.relation.isbasedon	10.1007/s10578-015-0579-2
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1103 Clinical Sciences, 1114 Paediatrics and Reproductive Medicine, 1701 Psychology
dc.subject.classification	Developmental & Child Psychology
dc.subject.mesh	Adolescent
dc.subject.mesh	Anxiety Disorders
dc.subject.mesh	Attentional Bias
dc.subject.mesh	Behavior Therapy
dc.subject.mesh	Child
dc.subject.mesh	Cognitive Behavioral Therapy
dc.subject.mesh	Female
dc.subject.mesh	Humans
dc.subject.mesh	Male
dc.subject.mesh	Parents
dc.subject.mesh	Perception
dc.subject.mesh	Phobic Disorders
dc.subject.mesh	Serotonin Uptake Inhibitors
dc.subject.mesh	Treatment Outcome
dc.subject.mesh	Humans
dc.subject.mesh	Serotonin Uptake Inhibitors
dc.subject.mesh	Treatment Outcome
dc.subject.mesh	Parents
dc.subject.mesh	Perception
dc.subject.mesh	Anxiety Disorders
dc.subject.mesh	Phobic Disorders
dc.subject.mesh	Behavior Therapy
dc.subject.mesh	Adolescent
dc.subject.mesh	Child
dc.subject.mesh	Female
dc.subject.mesh	Male
dc.subject.mesh	Attentional Bias
dc.subject.mesh	Cognitive Behavioral Therapy
dc.title	Parents' Perceptions of Novel Treatments for Child and Adolescent Specific Phobia and Anxiety Disorders.
dc.type	Journal Article
utslib.citation.volume	47
utslib.location.activity	United States
utslib.for	1103 Clinical Sciences
utslib.for	1114 Paediatrics and Reproductive Medicine
utslib.for	1701 Psychology
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
utslib.copyright.status	closed_access	*
dc.date.updated	2022-08-20T04:41:17Z
pubs.issue	3
pubs.publication-status	Published
pubs.volume	47
utslib.citation.issue	3

Abstract:

This study aimed to examine parents' perceptions of established treatments, including cognitive behaviour therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs), relative to novel treatments of D-cycloserine (DCS) and attention bias modification (ABM) augmented CBT to determine if novel treatments are perceived as more or less favorable than established treatments. Participants included parents of children with a specific phobia, enrolled in one of two randomized controlled trials of either one-session augmented DCS (n = 38, Gold Coast) or ABM augmented one-session treatment (n = 34, Brisbane), as well as parents from a community sample (n = 38). Parents of children with a specific phobia perceived CBT most favorably. There was no difference between the sites on perceptions of ABM. However, parents of children enrolled in the DCS trial perceived DCS more favorably than parents of children enrolled in the ABM trial and the community sample. These results demonstrate parents' greater acceptance of psychological treatments over pharmacological treatments for the treatment of childhood phobias, highlighting the importance of educating parents to novel treatments.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/160536